Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti-reward
β Scribed by Andrew H. Evans; Andrew D. Lawrence; Silke Appel Cresswell; Regina Katzenschlager; Andrew J. Lees
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 108 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
A few Parkinson patients develop a disabling pattern of compulsive dopaminergic drug use (''dopamine dysregulation syndrome''-DDS). DDS patients commonly identify aversive dysphoric ''OFF'' mood-states as a primary motivation to compulsively use their drugs. We compared motoric, affective, nonmotor symptoms and incentive arousal after overnight medication withdrawal and after levodopa in DDS and control PD patients. Twenty DDS patients were matched to 20 control PD patients for age, gender, and disease duration and underwent a standard levodopa challenge. Somatic symptomatology, positive and negative affective states, drug effects, reward responsivity, motor disability, and dyskinesias were tested in the ''OFF''-state after overnight withdrawal of medications, and then after a chal-lenge with a standard dose of levodopa, after a full ''ON''-state was achieved. In the ''OFF''-state, DDS patients reported lower positive affect, and more motor and non-motor disability. In the ''ON''-state, DDS patients had higher expressions of drug ''wanting,'' reward responsivity, and dyskinesias. Positive and negative affect, non-motor symptomatology, and motor disability were comparable. These findings suggest that affective, motivational, and motoric disturbances in PD are associated with the transition to compulsive drug use in individuals who inappropriately overuse their dopaminergic medication.
π SIMILAR VOLUMES
## Abstract We interviewed 300 patients (54.7% male; mean age was 65.8 Β± 9.5) attending the Movement Disorders Clinic at the Buenos Aires University Hospital to determine the prevalence of CATs use and their association with demographic, social, or diseaseβspecific characteristics among patients wi
The incidence of Parkinson's disease (PD) in sub-Saharan Africa (SSA) is greater than thought however, is largely undiagnosed and untreated. This study aimed to evaluate a nonpharmacological approach using cueing therapy to improve gait in drug-naΓ―ve PD and the feasibility of delivering rehabilitati
## Abstract Freezing is a disabling symptom in patients with Parkinson's disease. We investigated the effectiveness of a new rehabilitation strategy based on treadmill training associated with auditory and visual cues. Forty Parkinsonian patients with freezing were randomly assigned to two groups:
## Abstract ## Objective The Disease Activity Score (DAS) is widely used in clinical trials. A DAS of 5.1 defines the level of severe rheumatoid arthritis (RA) and is the criterion for the initiation of antiβtumor necrosis factor therapy in the UK and The Netherlands. In North America, similar rul